Detalhe da pesquisa
1.
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study.
Chin J Cancer Res
; 36(1): 78-89, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38455365
2.
China special issue on gastrointestinal tumors-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment.
Int J Cancer
; 153(11): 1916-1927, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36946696
3.
First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detection.
Eur J Nucl Med Mol Imaging
; 50(9): 2802-2817, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099132
4.
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients.
Cancer Immunol Immunother
; 71(1): 111-120, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028566
5.
Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
BMC Med
; 20(1): 223, 2022 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35811317
6.
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Lancet Oncol
; 22(8): 1081-1092, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34252374
7.
The Inconsistent and Inadequate Reporting Of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials.
Oncologist
; 26(12): e2239-e2246, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34396642
8.
Impact of 68Ga-NOTA-MAL-MZHER2 PET imaging in advanced gastric cancer patients and therapeutic response monitoring.
Eur J Nucl Med Mol Imaging
; 48(1): 161-175, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564171
9.
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors.
Gastric Cancer
; 24(4): 913-925, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945049
10.
Clinical trial analysis of 2019-nCoV therapy registered in China.
J Med Virol
; 92(6): 540-545, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32108352
11.
Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives.
Chin J Cancer Res
; 32(3): 287-302, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694895
12.
Correction: Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
BMC Med
; 21(1): 369, 2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37775728
13.
Response to "Comments on 'Zhang et al: Clinical trial analysis of 2019-nCoV therapy registered in China'".
J Med Virol
; 92(7): 713, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232977
14.
Claudin 18.2 as a novel therapeutic target.
Nat Rev Clin Oncol
; 21(5): 354-369, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503878
15.
68Ga-NC-BCH Whole-Body PET Imaging Rapidly Targets Claudin18.2 in Lesions in Gastrointestinal Cancer Patients.
J Nucl Med
; 65(6): 856-863, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604764
16.
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials.
J Clin Oncol
; : JCO2302314, 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38788174
17.
Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and expansion phase 1 trial.
EClinicalMedicine
; 68: 102415, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235421
18.
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results.
Nat Med
; 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38830992
19.
Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET-amplified gastric cancer.
Cancer Med
; 12(19): 19583-19594, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772487
20.
CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer.
J Hematol Oncol
; 16(1): 102, 2023 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37689733